Bianca Cuffa

Salerno, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case.

Next generation sequencing reveals spatio-temporal clonal heterogeneity in an aggressive relapsed/refractory multiple myeloma case.

Journal: Cancer genetics

Published: January 17, 2026

Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies.

Plasma Elastase Screening in Hematological Disease Reveals Its Potential as a Diagnostic and Prognostic Biomarker in Hematological Malignancies.

Journal: International journal of laboratory hematology

Published: September 10, 2025

Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a single-center case series study.

Distinct immunologic kinetics and cytomegalovirus reactivation incidence with rituximab- versus obinutuzumab-bendamustine in follicular lymphoma: a single-center case series study.

Journal: Journal of cancer research and clinical oncology

Published: September 06, 2025

Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies.

Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies.

Journal: Clinical and experimental medicine

Published: January 27, 2024

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.

Journal: Targeted oncology

Published: September 08, 2023

Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review.

Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review.

Journal: Acta haematologica

Published: January 15, 2023

Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring.

Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring.

Journal: Journal of immunological methods

Published: August 25, 2022

Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma.

Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma.

Journal: Mediterranean journal of hematology and infectious diseases

Published: March 12, 2022

A Case Series of Blastic Plasmacytoid Dendritic Cell Neoplasia.

A Case Series of Blastic Plasmacytoid Dendritic Cell Neoplasia.

Journal: Translational medicine @ UniSa

Published: January 18, 2021

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study.

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study.

Journal: Frontiers in pharmacology

Published: May 01, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026